| Date Filed | Type | Description |
| 08/25/2023 |
SC 13G
| Samsara BioCapital, L.P. reports a 5.6% stake in Lyra Therapeutics, Inc. |
| 02/24/2023 |
SC 13D
| Samsara BioCapital, L.P. reports a 11.1% stake in Mineralys Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| Samsara BioCapital, L.P. reports a 14.6% stake in Graphite Bio, Inc. |
| 02/14/2023 |
SC 13D
| Samsara BioCapital, L.P. reports a 10.8% stake in Scholar Rock Holding Corporation |
| 02/14/2023 |
SC 13G
| Samsara BioCapital, L.P. reports a 9.1% stake in Rain Oncology Inc. |
| 02/14/2023 |
SC 13D/A
| Samsara BioCapital, L.P. reports a 5.9% stake in Nkarta, Inc. |
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2023 |
3
| AKKARAJU SRINIVAS (10% Owner) has filed a Form 3 on Mineralys Therapeutics, Inc. |
| 06/01/2022 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 04/13/2022 |
4
| Samsara BioCapital, L.P. (10% Owner) has filed a Form 4 on Graphite Bio, Inc.|
Txns:
| Bought 74,464 shares
@ $4.07, valued at
$303.1k
Bought 350,000 shares
@ $4.08, valued at
$1.4M
|
|
| 02/14/2022 |
SC 13G/A
| Samsara BioCapital, L.P. reports a 13.5% stake in Graphite Bio, Inc. |
| 01/25/2022 |
4
| Samsara BioCapital, L.P. (10% Owner) has filed a Form 4 on Graphite Bio, Inc.|
Txns:
| Bought 100,000 shares
@ $8.99, valued at
$899k
Bought 23,000 shares
@ $8.7, valued at
$200.1k
|
|
| 01/21/2022 |
4
| Samsara BioCapital, L.P. (10% Owner) has filed a Form 4 on Graphite Bio, Inc.|
Txns:
| Bought 54,565 shares
@ $9.24, valued at
$504.2k
Bought 43,105 shares
@ $8.92, valued at
$384.5k
|
|
| 12/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/24/2021 |
4
| Samsara BioCapital, L.P. (10% Owner) has filed a Form 4 on Graphite Bio, Inc.|
Txns:
| Bought 201,685 shares
@ $10.15, valued at
$2M
|
|
| 10/15/2021 |
4
| Samsara BioCapital, L.P. (10% Owner) has filed a Form 4 on Graphite Bio, Inc.|
Txns:
| Bought 45,400 shares
@ $13.22, valued at
$600.2k
Bought 3,100 shares
@ $12.5, valued at
$38.8k
Bought 2,300 shares
@ $12.49, valued at
$28.7k
|
|
| 10/08/2021 |
4
| Samsara BioCapital, L.P. (10% Owner) has filed a Form 4 on Graphite Bio, Inc.|
Txns:
| Bought 61,475 shares
@ $13.83, valued at
$850.2k
Bought 9,021 shares
@ $14.94, valued at
$134.8k
Bought 75,000 shares
@ $13.12, valued at
$984k
|
|
| 07/09/2021 |
SC 13G
| Samsara BioCapital, L.P. reports a 12.8% stake in Graphite Bio, Inc. |
| 07/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/31/2020 |
D
| Form D - Notice of Exempt Offering of Securities: |
| 07/22/2020 |
SC 13D
| Samsara BioCapital, L.P. reports a 6.3% stake in Nkarta, Inc. |
| 03/06/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 03/05/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 03/22/2018 |
D/A
| Form D/A - Notice of Exempt Offering of Securities: [Amend] |
| 03/21/2017 |
D
| Form D - Notice of Exempt Offering of Securities |